Sorensis Pty Ltd

Dr Kim Agnew - CEO/Founder, Dr Rob Hunter - CSO Background polymer technology developed by Pendant BioSciences (Shawn Glinter CEO/Founder). Sorensis will introduce next generation polymer technology into the Animal Health industry which will provide an unparalleled level of tunable functionality in matching polymer matrix to the API (Active Pharmaceutical Ingredient). Slow-release technology has enormous potential to improve owner compliance with medications, allow therapeutic levels of selected actives to be maintained for extended periods and offer novel delivery systems into hard to effectively medicate spaces (e.g eyes, joints). Sorensis is species agnostic but we do have specific expertise either in house or externally available in bovine, canine, feline and equine.